Is Neoadjuvant Chemoradiotherapy Beneficial for Patients With Pancreatic Cancer?

Affiliations

¹ Pawel Mroczkowski, MD, PhD, Department of Surgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr-University-Bochum, Bochum, Germany, An-Istitut for Quality Assurance in the Operative Medicine Ltd, Otto-von-Guericke-University-Magdeburg, Magdeburg, Germany, Department for General and Colorectal Surgery, Medical University of Łódź, Lodz, Poland; and Radoslaw Zajdel, Department of Medical Informatics and Statistics, Medical University of Łódź, Lodz, Poland.

Comment

Pawel Mroczkowski et al. J Clin Oncol. 2022.

. 2022 Oct 1;40(28):3347-3348.

doi: 10.1200/JCO.22.00454. Epub 2022 Jun 23.

¹ Pawel Mroczkowski, MD, PhD, Department of Surgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr-University-Bochum, Bochum, Germany, An-Istitut for Quality Assurance in the Operative Medicine Ltd, Otto-von-Guericke-University-Magdeburg, Magdeburg, Germany, Department for General and Colorectal Surgery, Medical University of Łódź, Lodz, Poland; and Radoslaw Zajdel, Department of Medical Informatics and Statistics, Medical University of Łódź, Lodz, Poland.

No abstract available

Comment in

Reply to W. Attaallah, A. Jain et al, and P. Mroczkowski et al.
Versteijne E, van Dam JL, Besselink MG, Groot Koerkamp B, Homs MYV, Wilmink JW, van Eijck CH, van Tienhoven G. Versteijne E, et al. J Clin Oncol. 2022 Oct 1;40(28):3348-3351. doi: 10.1200/JCO.22.00875. Epub 2022 Jun 23. J Clin Oncol. 2022. PMID: 35737926 No abstract available.

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.
Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Tienhoven G, van Eijck CHJ; Dutch Pancreatic Cancer Group. Versteijne E, et al. J Clin Oncol. 2022 Apr 10;40(11):1220-1230. doi: 10.1200/JCO.21.02233. Epub 2022 Jan 27. J Clin Oncol. 2022. PMID: 35084987 Clinical Trial.